Cane Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.42M Buy
3,818
+420
+12% +$496K 1.64% 17
2026
Q2
$4.08M Buy
3,398
+26
+0.8% +$26.6K 1.61% 18
2026
Q1
$3.1M Buy
3,372
+965
+40% +$978K 1.35% 18
2025
Q4
$2.59M Hold
2,407
– – 1.02% 24

Other funds holding LLY

Cane Capital Partners's LLY Position: Q3 2026 in Review

Cane Capital Partners increased its Eli Lilly (LLY) stake by 12% in Q3 2026, buying an estimated $496K and bringing the position to 3,818 shares worth $4.42M. The position accounts for 1.64% of the portfolio, ranked #17.

Cane Capital Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cane Capital Partners held 3,818 shares of Eli Lilly worth $4.42M as of Q3 2026.
  • Cane Capital Partners bought 420 Eli Lilly shares in Q3 2026, an estimated $496K.
  • Eli Lilly made up 1.64% of Cane Capital Partners's portfolio in Q3 2026, its #17 holding.
  • Cane Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cane Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.